Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Saltzberg DJ"'
Autor:
Rafiei A; Department of Chemistry, University of Calgary, Calgary, Canada., Cruz Tetlalmatzi S; Department of Biology, McGill University, Montréal, Canada., Edrington CH; Department of Biology, McGill University, Montréal, Canada., Lee L; Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada., Crowder DA; Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada., Saltzberg DJ; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States., Sali A; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States.; Department of Pharmaceutical Chemistry, California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, United States., Brouhard G; Department of Biology, McGill University, Montréal, Canada., Schriemer DC; Department of Chemistry, University of Calgary, Calgary, Canada.; Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada.
Publikováno v:
ELife [Elife] 2022 Apr 29; Vol. 11. Date of Electronic Publication: 2022 Apr 29.
Autor:
Hepburn M; Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada., Saltzberg DJ; Department of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Sciences, and California Institute for Quantitative Biomedical Sciences, University of California, San Francisco, CA 94158, USA., Lee L; Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada., Fang S; Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada., Atkinson C; Department of Biochemistry and Molecular Biology and High-Resolution Macromolecular Electron Microscopy Facility, The University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada., Strynadka NCJ; Department of Biochemistry and Molecular Biology and High-Resolution Macromolecular Electron Microscopy Facility, The University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada., Sali A; Department of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Sciences, and California Institute for Quantitative Biomedical Sciences, University of California, San Francisco, CA 94158, USA., Lees-Miller SP; Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada; Robson DNA Science Centre, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Schriemer DC; Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada; Robson DNA Science Centre, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada; Department of Chemistry, University of Calgary, Calgary, AB, Canada. Electronic address: dschriem@ucalgary.ca.
Publikováno v:
Structure (London, England : 1993) [Structure] 2021 May 06; Vol. 29 (5), pp. 467-478.e6. Date of Electronic Publication: 2021 Jan 06.
Autor:
Saltzberg DJ; Department of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry, and California Institute for Quantitative Biosciences, University of California, San Francisco, California, USA., Viswanath S; National Center for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India., Echeverria I; Department of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry, and California Institute for Quantitative Biosciences, University of California, San Francisco, California, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA., Chemmama IE; Department of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry, and California Institute for Quantitative Biosciences, University of California, San Francisco, California, USA., Webb B; Department of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry, and California Institute for Quantitative Biosciences, University of California, San Francisco, California, USA., Sali A; Department of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry, and California Institute for Quantitative Biosciences, University of California, San Francisco, California, USA.
Publikováno v:
Protein science : a publication of the Protein Society [Protein Sci] 2021 Jan; Vol. 30 (1), pp. 250-261. Date of Electronic Publication: 2020 Dec 03.
Autor:
Gordon DE; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Jang GM; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Bouhaddou M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Xu J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Obernier K; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., White KM; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., O'Meara MJ; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA., Rezelj VV; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France., Guo JZ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Swaney DL; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Tummino TA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA., Hüttenhain R; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Kaake RM; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Richards AL; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Tutuncuoglu B; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Foussard H; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Batra J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Haas K; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Modak M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Kim M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Haas P; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Polacco BJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Braberg H; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Fabius JM; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Eckhardt M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Soucheray M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Bennett MJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Cakir M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., McGregor MJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Li Q; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Meyer B; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France., Roesch F; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France., Vallet T; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France., Mac Kain A; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France., Miorin L; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Moreno E; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Naing ZZC; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Zhou Y; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Peng S; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA., Shi Y; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA., Zhang Z; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA., Shen W; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA., Kirby IT; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA., Melnyk JE; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA., Chorba JS; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA., Lou K; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA., Dai SA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA., Barrio-Hernandez I; European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK., Memon D; European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK., Hernandez-Armenta C; European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK., Lyu J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA., Mathy CJP; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; The UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA., Perica T; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA., Pilla KB; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA., Ganesan SJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA., Saltzberg DJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA., Rakesh R; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA., Liu X; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA., Rosenthal SB; Center for Computational Biology and Bioinformatics, Department of Medicine, University of California San Diego, San Diego, CA, USA., Calviello L; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA., Venkataramanan S; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA., Liboy-Lugo J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA., Lin Y; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA., Huang XP; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA., Liu Y; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA., Wankowicz SA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; Biophysics Graduate Program, University of California San Francisco, San Francisco, CA, USA., Bohn M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA., Safari M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA., Ugur FS; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA., Koh C; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France., Savar NS; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France., Tran QD; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France., Shengjuler D; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France., Fletcher SJ; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France., O'Neal MC; Zoic Labs, Culver City, CA, USA., Cai Y; Zoic Labs, Culver City, CA, USA., Chang JCJ; Zoic Labs, Culver City, CA, USA., Broadhurst DJ; Zoic Labs, Culver City, CA, USA., Klippsten S; Zoic Labs, Culver City, CA, USA., Sharp PP; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Wenzell NA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Kuzuoglu-Ozturk D; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Department of Urology, University of California San Francisco, San Francisco, CA, USA., Wang HY; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Trenker R; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA., Young JM; Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Cavero DA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA., Hiatt J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Medical Scientist Training Program, University of California San Francisco, San Francisco, CA, USA., Roth TL; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.; Medical Scientist Training Program, University of California San Francisco, San Francisco, CA, USA., Rathore U; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA., Subramanian A; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA., Noack J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA., Hubert M; Virus and Immunity Unit, Institut Pasteur, Paris, France., Stroud RM; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA., Frankel AD; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA., Rosenberg OS; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Verba KA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA., Agard DA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA., Ott M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Emerman M; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Jura N; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA., von Zastrow M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Department of Psychiatry, University of California San Francisco, San Francisco, CA, USA., Verdin E; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Buck Institute for Research on Aging, Novato, CA, USA., Ashworth A; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Schwartz O; Virus and Immunity Unit, Institut Pasteur, Paris, France., d'Enfert C; Direction Scientifique, Institut Pasteur, Paris, France., Mukherjee S; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA., Jacobson M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA., Malik HS; Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Fujimori DG; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA., Ideker T; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Division of Genetics, Department of Medicine, University of California San Diego, San Diego, CA, USA., Craik CS; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Floor SN; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Fraser JS; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA., Gross JD; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA., Sali A; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA., Roth BL; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA., Ruggero D; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Department of Urology, University of California San Francisco, San Francisco, CA, USA., Taunton J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Kortemme T; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; The UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA., Beltrao P; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK., Vignuzzi M; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France. marco.vignuzzi@pasteur.fr., García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Adolfo.Garcia-Sastre@mssm.edu.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Adolfo.Garcia-Sastre@mssm.edu.; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Adolfo.Garcia-Sastre@mssm.edu.; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Adolfo.Garcia-Sastre@mssm.edu., Shokat KM; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA. Kevan.Shokat@ucsf.edu.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA. Kevan.Shokat@ucsf.edu.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA. Kevan.Shokat@ucsf.edu.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA. Kevan.Shokat@ucsf.edu., Shoichet BK; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA. shoichet@cgl.ucsf.edu.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA. shoichet@cgl.ucsf.edu.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA. shoichet@cgl.ucsf.edu., Krogan NJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA. nevan.krogan@ucsf.edu.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA. nevan.krogan@ucsf.edu.; J. David Gladstone Institutes, San Francisco, CA, USA. nevan.krogan@ucsf.edu.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA. nevan.krogan@ucsf.edu.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. nevan.krogan@ucsf.edu.
Publikováno v:
Nature [Nature] 2020 Jul; Vol. 583 (7816), pp. 459-468. Date of Electronic Publication: 2020 Apr 30.
Autor:
Gordon DE; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Jang GM; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Bouhaddou M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Xu J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Obernier K; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., O'Meara MJ; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, 48109, USA., Guo JZ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Swaney DL; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Tummino TA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco., Huettenhain R; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Kaake RM; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Richards AL; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Tutuncuoglu B; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Foussard H; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Batra J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Haas K; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Modak M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Kim M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Haas P; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Polacco BJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Braberg H; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Fabius JM; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Eckhardt M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Soucheray M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Bennett MJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Cakir M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., McGregor MJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Li Q; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Naing ZZC; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Zhou Y; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Peng S; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco., Kirby IT; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute., Melnyk JE; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute., Chorba JS; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute., Lou K; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute., Dai SA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute., Shen W; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute., Shi Y; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute., Zhang Z; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute., Barrio-Hernandez I; European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Memon D; European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Hernandez-Armenta C; European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Mathy CJP; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.; The UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA., Perica T; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco., Pilla KB; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco., Ganesan SJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco., Saltzberg DJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco., Ramachandran R; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco., Liu X; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco., Rosenthal SB; Center for Computational Biology and Bioinformatics, Department of Medicine, University of California San Diego., Calviello L; Department of Cell and Tissue Biology, University of California, San Francisco., Venkataramanan S; Department of Cell and Tissue Biology, University of California, San Francisco., Liboy-Lugo J; Department of Cell and Tissue Biology, University of California, San Francisco., Lin Y; Department of Cell and Tissue Biology, University of California, San Francisco., Wankowicz SA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; Biophysics Graduate Program, University of California, San Francisco.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco., Bohn M; Department of Pharmaceutical Chemistry, University of California, San Francisco., Sharp PP; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Trenker R; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, 94158, USA., Young JM; Division of Basic Sciences, Fred Hutchinson Cancer Research Center., Cavero DA; J. David Gladstone Institutes, San Francisco, CA 94158, USA., Hiatt J; Medical Scientist Training Program, University of California, San Francisco, CA 94143, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA., Roth TL; Medical Scientist Training Program, University of California, San Francisco, CA 94143, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA., Rathore U; J. David Gladstone Institutes, San Francisco, CA 94158, USA., Subramanian A; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, UC San Francisco., Noack J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, UC San Francisco., Hubert M; Virus and Immunity Unit, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris Cedex 15, France., Roesch F; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris cedex 15, France., Vallet T; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris cedex 15, France., Meyer B; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris cedex 15, France., White KM; Department for Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY., Miorin L; Department for Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY., Rosenberg OS; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.; Chan-Zuckerberg Biohub., Verba KA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco., Agard D; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; Biochemistry & Biophysics and Quantitative Biosciences Institute UCSF 600 16th St San Francisco, CA 94143., Ott M; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Emerman M; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98103., Ruggero D; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., García-Sastre A; Department for Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY., Jura N; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., von Zastrow M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Psychiatry, San Francisco, CA, 94158, USA., Taunton J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA., Ashworth A; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, 94158, USA., Schwartz O; Virus and Immunity Unit, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris Cedex 15, France., Vignuzzi M; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris cedex 15, France., d'Enfert C; Direction Scientifique, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris cedex 15, France., Mukherjee S; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, UC San Francisco., Jacobson M; Department of Pharmaceutical Chemistry, University of California, San Francisco., Malik HS; Division of Basic Sciences, Fred Hutchinson Cancer Research Center., Fujimori DG; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco., Ideker T; Division of Genetics, Department of Medicine, University of California San Diego., Craik CS; Department of Pharmaceutical Chemistry, University of California, San Francisco.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, 94158, USA., Floor S; Department of Cell and Tissue Biology, University of California, San Francisco.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, 94158, USA., Fraser JS; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco., Gross J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco., Sali A; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco., Kortemme T; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.; The UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA., Beltrao P; European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Shokat K; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute., Shoichet BK; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco., Krogan NJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2020 Mar 27. Date of Electronic Publication: 2020 Mar 27.
Autor:
Saltzberg DJ; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, USA. Electronic address: saltzberg@salilab.org., Hepburn M; Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada., Pilla KB; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, USA., Schriemer DC; Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada., Lees-Miller SP; Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada., Blundell TL; Department of Biochemistry, University of Cambridge, Cambridge, UK., Sali A; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, USA.
Publikováno v:
Progress in biophysics and molecular biology [Prog Biophys Mol Biol] 2019 Oct; Vol. 147, pp. 92-102. Date of Electronic Publication: 2019 Sep 27.
Publikováno v:
Journal of the American Chemical Society [J Am Chem Soc] 2019 May 08; Vol. 141 (18), pp. 7320-7326. Date of Electronic Publication: 2019 Apr 24.
Autor:
Saltzberg DJ; Department of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry, and California Institute for Quantitative Biosciences (QB3), University of California, San Francisco , San Francisco, California, United States., Broughton HB; Centro de Investigación Lilly, SA , Avenida de la Industria 30, 28108 Alcobendas, Spain., Pellarin R; Department of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry, and California Institute for Quantitative Biosciences (QB3), University of California, San Francisco , San Francisco, California, United States.; Structural Bioinformatics Unit, Institut Pasteur, CNRS UMR 3528 , Paris, France., Chalmers MJ; Lilly Research Laboratories, Eli Lilly and Company , Indianapolis, Indiana, United States., Espada A; Centro de Investigación Lilly, SA , Avenida de la Industria 30, 28108 Alcobendas, Spain., Dodge JA; Lilly Research Laboratories, Eli Lilly and Company , Indianapolis, Indiana, United States., Pascal BD; Bioinformatics Core, The Scripps Research Institute-Scripps Florida , Jupiter, Florida, United States., Griffin PR; Department of Molecular Therapeutics, The Scripps Research Institute-Scripps Florida , Jupiter, Florida, United States., Humblet C; Lilly Research Laboratories, Eli Lilly and Company , Indianapolis, Indiana, United States., Sali A; Department of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry, and California Institute for Quantitative Biosciences (QB3), University of California, San Francisco , San Francisco, California, United States.
Publikováno v:
The journal of physical chemistry. B [J Phys Chem B] 2017 Apr 20; Vol. 121 (15), pp. 3493-3501. Date of Electronic Publication: 2016 Dec 01.
Autor:
Watts JC; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, California, USA Department of Neurology, University of California, San Francisco, San Francisco, California, USA., Giles K; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, California, USA Department of Neurology, University of California, San Francisco, San Francisco, California, USA., Saltzberg DJ; California Institute for Quantitative Biosciences (QB3), University of California, San Francisco, San Francisco, California, USA., Dugger BN; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, California, USA Department of Neurology, University of California, San Francisco, San Francisco, California, USA., Patel S; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, California, USA., Oehler A; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, California, USA., Bhardwaj S; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, California, USA., Sali A; California Institute for Quantitative Biosciences (QB3), University of California, San Francisco, San Francisco, California, USA Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, USA Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA., Prusiner SB; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, California, USA Department of Neurology, University of California, San Francisco, San Francisco, California, USA Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, California, USA stanley.prusiner@ucsf.edu.
Publikováno v:
Journal of virology [J Virol] 2016 Oct 14; Vol. 90 (21), pp. 9558-9569. Date of Electronic Publication: 2016 Oct 14 (Print Publication: 2016).
Autor:
Farelli JD; Department of Chemistry, Boston University, Boston, Massachusetts, United States of America., Galvin BD; New England Biolabs, Division of Parasitology, Ipswich, Massachusetts, United States of America., Li Z; New England Biolabs, Division of Parasitology, Ipswich, Massachusetts, United States of America., Liu C; Department of Chemistry and Chemical Biology, University of New Mexico, Albuquerque, New Mexico, United States of America., Aono M; Department of Chemistry, Boston University, Boston, Massachusetts, United States of America., Garland M; Department of Chemistry, Boston University, Boston, Massachusetts, United States of America., Hallett OE; Department of Chemistry, Boston University, Boston, Massachusetts, United States of America., Causey TB; New England Biolabs, Division of Parasitology, Ipswich, Massachusetts, United States of America., Ali-Reynolds A; New England Biolabs, Division of Parasitology, Ipswich, Massachusetts, United States of America., Saltzberg DJ; Department of Chemistry, Boston University, Boston, Massachusetts, United States of America., Carlow CK; New England Biolabs, Division of Parasitology, Ipswich, Massachusetts, United States of America., Dunaway-Mariano D; Department of Chemistry and Chemical Biology, University of New Mexico, Albuquerque, New Mexico, United States of America., Allen KN; Department of Chemistry, Boston University, Boston, Massachusetts, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2014 Jul 03; Vol. 10 (7), pp. e1004245. Date of Electronic Publication: 2014 Jul 03 (Print Publication: 2014).